Developer docs
API playgroundTry for free, no card

Search company profiles

ValidCare

Full company profile

uuid000ahoo

Namestring
ValidCare
Legal namestring
Validcare, LLC
Websiteurl
validcare.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Validcare, LLC is a performance-based Contract Research Organization founded in 2014 and headquartered in Castle Pines, Colorado, that delivers Real-Time Clinical Trials to emerging biotech, mid-market pharmaceutical, medical device, nutraceutical, and academic sponsors. The company operates a unified proprietary technology platform called SmartSource™, a 21 CFR Part 11-compliant cloud-based clinical trial system that integrates CTMS, EDC/eCRF, ePRO, eCOA, eConsent, randomization/IRT, safety/PV, eTMF/eISF, digital recruitment, and protocol deviation modules into a single architecture. The platform's distinguishing technical feature is Source Data Collection at the point of care, in which investigator entry serves as the source record — eliminating transcription and collapsing SDV scope — combined with continuous cleaning that achieves database lock in days after Last Patient Last Visit rather than weeks or months.

Validcare generates revenue through three streams: (1) full-service CRO engagements delivered under performance-based fixed-fee contracts covering protocol development, regulatory submissions, site management, monitoring, data management, biostatistics, and medical writing; (2) SmartSource platform licensing as a white-labelable platform-as-a-service (e.g., Florida International University's 'FIU Study'); and (3) risk-sharing commercial structures that include equity participation, shared enrollment risk, and milestone-based payments rather than hourly billing. The company maintains legal entities in 8 countries and operational reach across 40+ countries, with therapeutic depth spanning 20+ areas including women's health, oncology, cardiovascular, neurology, gastroenterology, and endocrinology.

The go-to-motion is direct enterprise sales supported by inside-sales inquiry handling, industry event presence (including the JPMorgan Healthcare Conference), content marketing via blog and newsletter, and partnership channels that double as distribution into academic institutions and emerging markets. Validcare is privately held with no disclosed external funding rounds, no parent company, and no subsidiaries beyond the integrated Real-World Research Ltd capability acquired in 2022.

Short descriptiontext

Validcare is a performance-based Contract Research Organization that delivers real-time clinical trials through its proprietary SmartSource™ platform, serving emerging biotech, mid-market pharma, medical device, and nutraceutical sponsors across 40+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNew Castle, United States
HQ citystring
New Castle
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research organization, clinical trial services, eClinical platform software, decentralized clinical trials, pharmaceutical CRO services
Industry6 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Custom Computer Programming Services541511
SIC code2 codes
  • Services-Computer Programming, Data Processing, Etc.7370
  • Services-Misc Health & Allied Services, Nec8090
Product category
Clinical Research Organization (CRO) Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Full-Service CRO Services
TypeProfessional Services
Description

Validcare operates as a full-service Contract Research Organization providing end-to-end clinical trial services including protocol development, regulatory support, site management, clinical monitoring, data management, biostatistics, medical writing, and safety management under a single contract.

validcare.com
2SmartSource™ Platform Licensing
TypeSubscription Recurring
Description

The SmartSource Clinical Trial Platform is offered as a platform-as-a-service (PaaS), available for white-labeling by partners and institutions (e.g., FIU white-labeled as 'FIU Study').

validcare.com
3Performance-Based Contracts
TypeUsage Based
Description

Fixed-fee contracts for setup and monthly study management with transparent pass-through costs and simple admin fee. Risk-sharing options include partial payment in equity, shared risk on enrollment rates, and milestone-based payments. No hourly billing or catch-all project management line items.

validcare.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Pricing details2 tiers
1Fixed-Fee Setup and Management
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Predictable, fixed fee for setup and monthly study management. Fixed fee for statistical analysis and study write-up. Transparent pass-through costs with simple admin fee.

validcare.com
2Risk-Sharing Options
ModelOutcome Based/ PerformanceBilling cadenceMulti-year contract
Notes

Partial payment in equity of sponsor's company. Shared risk on enrollment rates. Milestone-based payments tied to study milestones.

validcare.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Validcare operates as a performance-based, full-service Contract Research Organization (CRO) delivering end-to-end clinical trial services — including protocol development, regulatory support, site management, clinical monitoring, data management, biostatistics, medical writing, and safety management — underpinned by its proprietary SmartSource™ Clinical Trial Platform. The unified cloud platform enables Source Data Collection at the point of care, continuous cleaning, real-time stakeholder dashboards, and database lock in days after Last Patient Last Visit, delivered under fixed-fee, performance-based contracts with risk-sharing options.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Database lock achieved in days after Last Patient Last Visit - vs weeks/months traditional approach
+3 more records
Product overview1 text field

Validcare operates as a Performance-Based CRO delivering Real-Time Clinical Trials through its SmartSource™ Clinical Trial Platform — a unified platform-plus-modules architecture. The core SmartSource™ platform integrates CTMS, EDC (eCRF), ePRO, eCOA, eConsent, Randomization/IRT, Safety/PV Workflow, eTMF/eISF, Digital Recruitment, and Protocol Deviations modules into a single system. This platform powers Source Data Collection at the point of care and enables protocol-governed real-time access for sponsors, sites, participants, IRBs, and regulators. Validcare's Full-Service CRO offering combines this technology with comprehensive clinical trial services (protocol development, regulatory support, site management, monitoring, data management, biostatistics, medical writing) delivered under performance-based fixed-fee contracts.

Product and service3 records
1Full-Service CRO Services
CategoryClinical Research Organization (CRO) services
Description

End-to-end clinical trial services including protocol development, regulatory submissions, site selection and management, clinical monitoring, data management, biostatistics, medical writing, and safety/pharmacovigilance delivered as a single accountable engagement under performance-based contracting. Targeted at biotech, pharmaceutical, medical device, nutraceutical, and academic sponsors running Phase I–III trials, decentralized studies, IDE submissions, and real-world evidence studies.

2SmartSource™ Clinical Trial Platform
CategoryeClinical platform software (PaaS)
Description

Unified, cloud-based, 21 CFR Part 11 compliant platform-as-a-service integrating CTMS, EDC/eCRF, ePRO, eCOA, eConsent, Randomization/IRT, Safety/PV Workflow, eTMF/eISF, Digital Recruitment, and Protocol Deviations modules. Enables Source Data Collection at the point of care, continuous cleaning, AI-assisted anomaly detection, real-time sponsor dashboards, and protocol-governed stakeholder access for sponsors, sites, participants, IRBs, and regulators. Available for white-label PaaS deployment by partners and institutions (e.g., FIU's 'FIU Study').

3Source Data Collection Service
CategoryClinical trial data management methodology
Description

Operational methodology and service whereby clinical data are captured directly from investigators and patients at the point of care through the SmartSource platform, eliminating transcription errors, collapsing SDV scope, and enabling continuous cleaning throughout study execution. Delivered as part of Validcare's full-service CRO engagements and available wherever SmartSource is deployed.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-02
Description

Strategic alliance to provide emerging biotech and biopharma sponsors with a modernized, end-to-end experience making Real-Time Clinical Trials a reality. Integration of Univo IRB's efficient IRB model with Validcare's SmartSource™ platform delivers unprecedented real-time visibility into study data across the entire trial lifecycle for sponsors, investigators, and regulators.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-02-05
Description

CRO partnership for Phase 2a clinical study examining DMT treatment in stroke patients. Validcare committed to $170,000 equity investment in AGN Neuro staged progressively as the study advances. Alignment of financial incentives toward timely completion, budget adherence, and robust data quality.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-18
Description

CRO partnership for multi-center prospective study involving 160 women evaluating Vlisse vaginal cooling device for vulvovaginal candidiasis, with findings intended to support FDA market approval submission.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-05
Description

CRO partnership for presbyopia study evaluating proprietary qCXL™ technology. Services include protocol development, electronic source data collection, data management, and statistical analysis.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-09-19
Description

CRO partnership for 440-infant Growth Monitoring Study across 13 U.S. sites to support FDA market authorization for Bubs infant formula products. Study targeted completion before FDA September 2024 deadline.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-02-16
Description

Strategic partnership to enhance clinical trial execution in Latin America and emerging markets. Farmacon specializes in accelerating trials with expertise in rare disease, cancer, immunology, and infectious disease research. Partnership enables electronic case report forms, e-diaries, and real-world evidence applications.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2021-12-02
Description

Sole source agreement where FIU white-labels Validcare's platform as 'FIU Study' for hybrid and decentralized clinical trials. Platform supports iOS/Android apps, investigator portal, and support services across the institution.

8Garden of Life
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-11-11
Description

Partnership for largest clinical trial ever performed for women studying Dr. Formulated Women's Once Daily Probiotic supplement. Leverages Validcare's decentralized trial technology via branded mobile app for Android and iOS.

validcare.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Mid-sized, science-led full-service CRO with a strong technology backbone and a reputation for predictable, fixed-fee trial execution — the closest direct analogue to Validcare's performance-based, tech-embedded model.

TypeDirect peer
Description

Mid-market full-service CRO focused on complex Phase II/III trials across multiple therapeutic areas, comparable to Validcare in scale, sponsor mix, and reliance on differentiated operational models.

TypeBroad incumbent
Description

Top-five global CRO offering full-service clinical development plus laboratory and commercial services; broad incumbent competing across the same therapeutic and trial phases as Validcare.

TypeBroad incumbent
Description

Largest CRO and life-sciences technology platform — competes head-on with Validcare across full-service operations, eClinical software, and DCT enablement, but at far greater scale and breadth.

TypeBroad incumbent
Description

Full-service global CRO with strong biotech sponsor relationships and growing decentralized trial capabilities — directly comparable in target customer segment and trial complexity.

TypeBroad incumbent
Description

Early-stage CRO services and preclinical solutions provider whose discovery-to-Phase II suite overlaps with Validcare's biotech and emerging-sponsor focus areas.

TypeEmerging player
Description

Specialized eClinical technology provider (eCOA, cardiac safety, imaging) with similar decentralized trial DNA — overlaps with Validcare on the SmartSource platform layer more than on full-service operations.

TypeEmerging player
Description

Enterprise EDC and clinical cloud platform; competing with the SmartSource™ platform for sponsor eClinical mandates that anchor Validcare's performance-based CRO offering.

TypeBroad incumbent
Description

Life-sciences cloud platform with CTMS, eTMF, and clinical operations suites — competing for the same CRO technology budgets while extending into operational software adjacent to Validcare's stack.

10Biofourmis
TypeEmerging player
Description

Decentralized and hybrid trial enablement vendor leveraging connected biosensors and AI — intersects with Validcare's DCT capabilities and continuous-data-stream thesis but does not provide full-service CRO operations.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ValidCare

Clinical Research Organization (CRO) Servicesvalidcare.com

Validcare is a performance-based Contract Research Organization that delivers real-time clinical trials through its proprietary SmartSource™ platform, serving emerging biotech, mid-market pharma, medical device, and nutraceutical sponsors across 40+ countries.

What ValidCare does

Validcare, LLC is a performance-based Contract Research Organization founded in 2014 and headquartered in Castle Pines, Colorado, that delivers Real-Time Clinical Trials to emerging biotech, mid-market pharmaceutical, medical device, nutraceutical, and academic sponsors. The company operates a unified proprietary technology platform called SmartSource™, a 21 CFR Part 11-compliant cloud-based clinical trial system that integrates CTMS, EDC/eCRF, ePRO, eCOA, eConsent, randomization/IRT, safety/PV, eTMF/eISF, digital recruitment, and protocol deviation modules into a single architecture. The platform's distinguishing technical feature is Source Data Collection at the point of care, in which investigator entry serves as the source record — eliminating transcription and collapsing SDV scope — combined with continuous cleaning that achieves database lock in days after Last Patient Last Visit rather than weeks or months.

Validcare generates revenue through three streams: (1) full-service CRO engagements delivered under performance-based fixed-fee contracts covering protocol development, regulatory submissions, site management, monitoring, data management, biostatistics, and medical writing; (2) SmartSource platform licensing as a white-labelable platform-as-a-service (e.g., Florida International University's 'FIU Study'); and (3) risk-sharing commercial structures that include equity participation, shared enrollment risk, and milestone-based payments rather than hourly billing. The company maintains legal entities in 8 countries and operational reach across 40+ countries, with therapeutic depth spanning 20+ areas including women's health, oncology, cardiovascular, neurology, gastroenterology, and endocrinology.

The go-to-motion is direct enterprise sales supported by inside-sales inquiry handling, industry event presence (including the JPMorgan Healthcare Conference), content marketing via blog and newsletter, and partnership channels that double as distribution into academic institutions and emerging markets. Validcare is privately held with no disclosed external funding rounds, no parent company, and no subsidiaries beyond the integrated Real-World Research Ltd capability acquired in 2022.

ValidCare firmographics

Firmographics
Name
ValidCare
Legal name
Validcare, LLC
Website
https://validcare.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Validcare is a performance-based Contract Research Organization that delivers real-time clinical trials through its proprietary SmartSource™ platform, serving emerging biotech, mid-market pharma, medical device, and nutraceutical sponsors across 40+ countries.
Ownership category
akta.pro rank

ValidCare industry classification

Industry
Product category
Clinical Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417), Custom Computer Programming Services (541511)
SIC
Services-Computer Programming, Data Processing, Etc. (7370), Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLACAOAL
Decentralized/Hybrid Trial Enablement (DCT) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGAAAF
Clinical Data Management, Biostatistics & Statistical Programming CROs
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Keywords

  • Clinical research organization
  • Clinical trial services
  • EClinical platform software
  • Decentralized clinical trials
  • Pharmaceutical CRO services

Where ValidCare is headquartered

Location

Headquarters

HQ city
New Castle
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ValidCare business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. Full-Service CRO Services: Validcare operates as a full-service Contract Research Organization providing end-to-end clinical trial services including protocol development, regulatory support, site management, clinical monitoring, data management, biostatistics, medical writing, and safety management under a single contract.
  2. SmartSource™ Platform Licensing: The SmartSource Clinical Trial Platform is offered as a platform-as-a-service (PaaS), available for white-labeling by partners and institutions (e.g., FIU white-labeled as 'FIU Study').
  3. Performance-Based Contracts: Fixed-fee contracts for setup and monthly study management with transparent pass-through costs and simple admin fee. Risk-sharing options include partial payment in equity, shared risk on enrollment rates, and milestone-based payments. No hourly billing or catch-all project management line items.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractFixed-Fee Setup and Management
Outcome Based/ PerformanceMulti-year contractRisk-Sharing Options

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

ValidCare product offering

Product offering

Core offering

Validcare operates as a performance-based, full-service Contract Research Organization (CRO) delivering end-to-end clinical trial services — including protocol development, regulatory support, site management, clinical monitoring, data management, biostatistics, medical writing, and safety management — underpinned by its proprietary SmartSource™ Clinical Trial Platform. The unified cloud platform enables Source Data Collection at the point of care, continuous cleaning, real-time stakeholder dashboards, and database lock in days after Last Patient Last Visit, delivered under fixed-fee, performance-based contracts with risk-sharing options.

Product overview

Validcare operates as a Performance-Based CRO delivering Real-Time Clinical Trials through its SmartSource™ Clinical Trial Platform — a unified platform-plus-modules architecture. The core SmartSource™ platform integrates CTMS, EDC (eCRF), ePRO, eCOA, eConsent, Randomization/IRT, Safety/PV Workflow, eTMF/eISF, Digital Recruitment, and Protocol Deviations modules into a single system. This platform powers Source Data Collection at the point of care and enables protocol-governed real-time access for sponsors, sites, participants, IRBs, and regulators. Validcare's Full-Service CRO offering combines this technology with comprehensive clinical trial services (protocol development, regulatory support, site management, monitoring, data management, biostatistics, medical writing) delivered under performance-based fixed-fee contracts.

Differentiator

Problem solved

Functional benefit

Products and services

  • Full-Service CRO Services End-to-end clinical trial services including protocol development, regulatory submissions, site selection and management, clinical monitoring, data management, biostatistics, medical writing, and safety/pharmacovigilance delivered as a single accountable engagement under performance-based contracting. Targeted at biotech, pharmaceutical, medical device, nutraceutical, and academic sponsors running Phase I–III trials, decentralized studies, IDE submissions, and real-world evidence studies.
  • SmartSource™ Clinical Trial Platform Unified, cloud-based, 21 CFR Part 11 compliant platform-as-a-service integrating CTMS, EDC/eCRF, ePRO, eCOA, eConsent, Randomization/IRT, Safety/PV Workflow, eTMF/eISF, Digital Recruitment, and Protocol Deviations modules. Enables Source Data Collection at the point of care, continuous cleaning, AI-assisted anomaly detection, real-time sponsor dashboards, and protocol-governed stakeholder access for sponsors, sites, participants, IRBs, and regulators. Available for white-label PaaS deployment by partners and institutions (e.g., FIU's 'FIU Study').
  • Source Data Collection Service Operational methodology and service whereby clinical data are captured directly from investigators and patients at the point of care through the SmartSource platform, eliminating transcription errors, collapsing SDV scope, and enabling continuous cleaning throughout study execution. Delivered as part of Validcare's full-service CRO engagements and available wherever SmartSource is deployed.

Quantifiable outcome

  • Database lock achieved in days after Last Patient Last Visit - vs weeks/months traditional approach
  • +3 more outcomes

Companies that use ValidCare

Customer profile

Named customers9 records

Segments4 records

Ideal customer profiles2 records

ValidCare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability2 records

Feature6 records

ValidCare partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core.

  • Univo IRBcoreStrategic or Co-development Partner · 2 June 2026Strategic alliance to provide emerging biotech and biopharma sponsors with a modernized, end-to-end experience making Real-Time Clinical Trials a reality. Integration of Univo IRB's efficient IRB model with Validcare's SmartSource™ platform delivers unprecedented real-time visibility into study data across the entire trial lifecycle for sponsors, investigators, and regulators.
  • Algernon NeuroSciencecoreStrategic or Co-development Partner · 5 February 2025CRO partnership for Phase 2a clinical study examining DMT treatment in stroke patients. Validcare committed to $170,000 equity investment in AGN Neuro staged progressively as the study advances. Alignment of financial incentives toward timely completion, budget adherence, and robust data quality.
  • CoologicscoreStrategic or Co-development Partner · 18 January 2024CRO partnership for multi-center prospective study involving 160 women evaluating Vlisse vaginal cooling device for vulvovaginal candidiasis, with findings intended to support FDA market approval submission.
  • TECLenscoreStrategic or Co-development Partner · 5 January 2024CRO partnership for presbyopia study evaluating proprietary qCXL™ technology. Services include protocol development, electronic source data collection, data management, and statistical analysis.
  • Bubs AustraliacoreStrategic or Co-development Partner · 19 September 2023CRO partnership for 440-infant Growth Monitoring Study across 13 U.S. sites to support FDA market authorization for Bubs infant formula products. Study targeted completion before FDA September 2024 deadline.
  • Farmacon GlobalcoreChannel Partner/ Reseller/ Distributor · 16 February 2022Strategic partnership to enhance clinical trial execution in Latin America and emerging markets. Farmacon specializes in accelerating trials with expertise in rare disease, cancer, immunology, and infectious disease research. Partnership enables electronic case report forms, e-diaries, and real-world evidence applications.
  • Florida International UniversitycoreOEM/ Whitelabel/ Licensing Partner · 2 December 2021Sole source agreement where FIU white-labels Validcare's platform as 'FIU Study' for hybrid and decentralized clinical trials. Platform supports iOS/Android apps, investigator portal, and support services across the institution.
  • Garden of LifecoreStrategic or Co-development Partner · 11 November 2021Partnership for largest clinical trial ever performed for women studying Dr. Formulated Women's Once Daily Probiotic supplement. Leverages Validcare's decentralized trial technology via branded mobile app for Android and iOS.

Scale indicators6 records

Recent moves6 records

Expansion highlights7 records

ValidCare competitors and assessment

Company assessment

Direct peers

  • Medpace Holdings: Mid-sized, science-led full-service CRO with a strong technology backbone and a reputation for predictable, fixed-fee trial execution — the closest direct analogue to Validcare's performance-based, tech-embedded model.
  • Worldwide Clinical Trials: Mid-market full-service CRO focused on complex Phase II/III trials across multiple therapeutic areas, comparable to Validcare in scale, sponsor mix, and reliance on differentiated operational models.

Broad incumbents

  • ICON plc: Top-five global CRO offering full-service clinical development plus laboratory and commercial services; broad incumbent competing across the same therapeutic and trial phases as Validcare.
  • IQVIA: Largest CRO and life-sciences technology platform — competes head-on with Validcare across full-service operations, eClinical software, and DCT enablement, but at far greater scale and breadth.
  • Parexel International: Full-service global CRO with strong biotech sponsor relationships and growing decentralized trial capabilities — directly comparable in target customer segment and trial complexity.
  • Charles River Laboratories: Early-stage CRO services and preclinical solutions provider whose discovery-to-Phase II suite overlaps with Validcare's biotech and emerging-sponsor focus areas.
  • Veeva Systems: Life-sciences cloud platform with CTMS, eTMF, and clinical operations suites — competing for the same CRO technology budgets while extending into operational software adjacent to Validcare's stack.

Emerging players

  • Clario: Specialized eClinical technology provider (eCOA, cardiac safety, imaging) with similar decentralized trial DNA — overlaps with Validcare on the SmartSource platform layer more than on full-service operations.
  • Medidata Solutions (Dassault Systèmes): Enterprise EDC and clinical cloud platform; competing with the SmartSource™ platform for sponsor eClinical mandates that anchor Validcare's performance-based CRO offering.
  • Biofourmis: Decentralized and hybrid trial enablement vendor leveraging connected biosensors and AI — intersects with Validcare's DCT capabilities and continuous-data-stream thesis but does not provide full-service CRO operations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key highlights7 records

Customer concentration

ValidCare social profiles

Digital presence

ValidCare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ValidCare leadership team

Management profile

Number of profiles

Profiles3 records

ValidCare funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ValidCare M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ValidCare

What does ValidCare do?

Validcare operates as a performance-based, full-service Contract Research Organization (CRO) delivering end-to-end clinical trial services — including protocol development, regulatory support, site management, clinical monitoring, data management, biostatistics, medical writing, and safety management — underpinned by its proprietary SmartSource™ Clinical Trial Platform. The unified cloud platform enables Source Data Collection at the point of care, continuous cleaning, real-time stakeholder dashboards, and database lock in days after Last Patient Last Visit, delivered under fixed-fee, performance-based contracts with risk-sharing options.

Is ValidCare a public or private company?

ValidCare is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was ValidCare founded?

ValidCare was founded in 2014. It employs 11 to 50 people.

Where is ValidCare based?

ValidCare is headquartered in New Castle, United States, in the North America region.

How does ValidCare make money?

Three revenue lines are on record. Full-Service CRO Services are the primary driver. The others are smartSource™ Platform Licensing and performance-Based Contracts.

Who are ValidCare's main competitors?

Direct peers on record are Medpace Holdings and Worldwide Clinical Trials. Broad incumbents are ICON plc, IQVIA, Parexel International, Charles River Laboratories and Veeva Systems. Emerging players are Clario, Medidata Solutions (Dassault Systèmes) and Biofourmis.

Does ValidCare have an API?

No public API is recorded for ValidCare.

What industry is ValidCare in?

ValidCare's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLACAOAL, Decentralized/Hybrid Trial Enablement (DCT) Platforms. Its NAICS code is 5417 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireValidcare and Univo™ IRB Alliance Creates Reality of Real-Time Clinical TrialsValidcare and Univo IRB announced a strategic alliance to provide real-time visibility into clinical trial data across the study lifecycle. The partnership integrates Univo IRB's IRB model with Validcare's SmartSource platform, aiming to reduce lag times and lower costs. The alliance is bolstered by recent FDA guidance encouraging real-time data access.BioSpaceAlgernon NeuroScience Appoints Validcare as CRO for its Phase 2a DMT Human Stroke Trial and Announces Validcare’s USD $170K Equity InvestmentAlgernon NeuroScience appointed Validcare as CRO for its Phase 2a DMT stroke trial in Europe, with enrollment expected in Q3 2025. Validcare will invest $170K in exchange for equity, completed in stages. The company also cancelled 684,000 vested stock options.GlobeNewswireAlgernon NeuroScience Appoints Validcare as CRO for its Phase 2a DMT Human Stroke Trial and Announces Validcare’s USD $170K Equity InvestmentAlgernon NeuroScience appointed Validcare as CRO for its Phase 2a DMT stroke trial in Europe, with enrollment expected in Q3 2025. Validcare will invest $170K in exchange for equity, completed in stages. The company also cancelled 684,000 vested stock options.GlobeNewswireMedical Marijuana, Inc. Subsidiary Kannaway® Announces Positive Preliminary Results of Validcare CBD Safety StudyMedical Marijuana, Inc. announced positive preliminary results from a CBD safety study involving 1,061 U.S. participants and 17 CBD companies, including its subsidiary Kannaway. The results show daily CBD consumption is not associated with elevated liver tests, low testosterone, or daytime drowsiness. The company hopes the data will persuade the FDA to regulate CBD, potentially doubling the addressable market.BioSpaceFarmacon Global Partners With Validcare for Performance-Based Clinical Research SolutionsFarmacon Global partnered with Validcare to provide performance-based clinical research solutions, including site-based, hybrid, and decentralized trials. The collaboration aims to improve patient enrollment, site setup, and data integrity through e-CRF and e-diaries, targeting Latin America and emerging markets.GlobeNewswireTauriga Sciences Inc. Showcases Blister Pack Design for its Evergreen Mint Flavor, Delta 8 THC Infused, Version of Tauri-GumTauriga Sciences showcased its Delta 8 THC-infused Tauri-Gum in an Evergreen Mint flavor, with each piece containing 10mg of Delta 8 THC and an MSRP of $18.99 per blister pack. The product is currently in production, and the company also announced approval to participate in a Validcare safety study for its CBD-based anti-nausea gum.PR NewswireHemp Industry Leader SunFlora Completes Participation in ValidCare Seven-Month-Long Clinical CBD Study on Liver ToxicitySunFlora, a CBD brand and creator of SUNMED products, has completed participation in a seven-month ValidCare clinical study on liver toxicity involving 839 subjects, with preliminary results showing zero instances of liver toxicity or disease. The study was commissioned in response to the FDA's request to gather scientific data to help determine the appropriate regulatory path for hemp-derived CBD products. SunFlora and 11 other hemp companies funded and provided products for the research, with findings delivered to participating brands and the FDA.PR NewswireLandmark CBD Study Concludes; Positive Results Reinforce Care By Design's Commitment to Patient SafetyA clinical study commissioned by the FDA and conducted by ValidCare, involving Care By Design products, concluded that daily CBD use for at least 60 days showed no evidence of liver toxicity in participants. The research observed 839 adults and found only three cases of elevated liver enzymes, which were attributed to concurrent prescription medications rather than CBD itself. These positive safety results have been reported to the FDA to help inform regulatory decisions regarding hemp-derived CBD products.GlobeNewswireMedical Marijuana, Inc. Subsidiary Kannaway® Announces Positive Preliminary Results of Validcare Clinical Study on CBD Liver ToxicityMedical Marijuana, Inc. announced positive preliminary results from a Validcare clinical study on CBD liver toxicity, showing no evidence of liver toxicity in 839 participants who ingested hemp-derived CBD for at least 60 days. The findings were shared with the FDA Cannabis Product Council on March 15, 2021, to support regulatory data on botanical CBD.PR NewswireNew Validcare Clinical Study Reports Preliminary Results of CBD Liver SafetyBalanced Health Botanicals announced preliminary findings from Validcare's CBD Liver Safety Study, which involved 839 participants and showed no evidence of liver disease or increased prevalence of elevated liver function tests compared to a similar population. The study was conducted in response to the FDA's 2020 call for increased science-backed data on CBD products, with principal investigators meeting with the FDA on March 15, 2021 to review results. Twelve product-based CBD companies, led by CBDistillery, provided funding, product, and assisted with recruitment for the study conducted between August 2020 and February 2021.